Mortality burden of the 1918-1919 influenza pandemic in Europe.

Séverine Ansart, Camille Pelat, Pierre-Yves Boelle, Fabrice Carrat, Antoine Flahault, Alain-Jacques Valleron
Author Information
  1. Séverine Ansart: INSERM, U 707, Paris, France.

Abstract

BACKGROUND: The origin and estimated death toll of the 1918-1919 epidemic are still debated. Europe, one of the candidate sites for pandemic emergence, has detailed pandemic mortality information.
OBJECTIVE: To determine the mortality impact of the 1918 pandemic in 14 European countries, accounting for approximately three-quarters of the European population (250 million in 1918).
METHODS: We analyzed monthly all-cause civilian mortality rates in the 14 countries, accounting for approximately three-quarters of the European population (250 million in 1918). A periodic regression model was applied to estimate excess mortality from 1906 to 1922. Using the 1906-1917 data as a training set, the method provided a non-epidemic baseline for 1918-1922. Excess mortality was the mortality observed above this baseline. It represents the upper bound of the mortality attributable to the flu pandemic.
RESULTS: Our analysis suggests that 2.64 million excess deaths occurred in Europe during the period when Spanish flu was circulating. The method provided space variation of the excess mortality: the highest and lowest cumulative excess/predicted mortality ratios were observed in Italy (+172%) and Finland (+33%). Excess-death curves showed high synchrony in 1918-1919 with peak mortality occurring in all countries during a 2-month window (Oct-Nov 1918).
CONCLUSIONS: During the Spanish flu, the excess mortality was 1.1% of the European population. Our study highlights the synchrony of the mortality waves in the different countries, which pleads against a European origin of the pandemic, as was sometimes hypothesized.

References

  1. Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1857-9 [PMID: 11779384]
  2. Indian Econ Soc Hist Rev. 1986;23(1):1-40 [PMID: 11617178]
  3. Emerg Infect Dis. 2006 Jan;12(1):15-22 [PMID: 16494711]
  4. Rev Med Virol. 2000 Mar-Apr;10(2):119-33 [PMID: 10713598]
  5. Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1829-39 [PMID: 11779381]
  6. Emerg Infect Dis. 2006 Jan;12(1):34-9 [PMID: 16494714]
  7. Soc Sci Med. 1983;17(17):1299-307 [PMID: 6356369]
  8. J Appl Microbiol. 2001 Oct;91(4):572-9 [PMID: 11576290]
  9. BMC Med Inform Decis Mak. 2007 Oct 15;7:29 [PMID: 17937786]
  10. Vaccine. 2005 Jan 4;23(7):940-5 [PMID: 15603896]
  11. Science. 1997 Mar 21;275(5307):1793-6 [PMID: 9065404]
  12. Lancet Infect Dis. 2002 Feb;2(2):111-4 [PMID: 11901642]
  13. Emerg Infect Dis. 2006 Jan;12(1):9-14 [PMID: 16494710]
  14. Lancet. 2006 Dec 23;368(9554):2211-8 [PMID: 17189032]
  15. Bull Hist Med. 1991 Spring;65(1):4-21 [PMID: 2021692]
  16. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11059-63 [PMID: 16046546]
  17. Epidemiol Rev. 1996;18(1):64-76 [PMID: 8877331]
  18. Bull Hist Med. 2002 Spring;76(1):105-15 [PMID: 11875246]
  19. Euro Surveill. 2002 Dec;7(12):190-2 [PMID: 12631986]

MeSH Term

Disease Outbreaks
Europe
History, 20th Century
Humans
Influenza, Human
Models, Statistical